REQUEST A DEMO
Total
USD $0.00
Search more companies

Labomedica Ecuador Labomec S.A.S. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Labomedica Ecuador Labomec S.A.S. Profile Updated: September 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Labomedica Ecuador Labomec S.A.S. is based in Ecuador. The head office is in Guayaquil. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on April 27, 2023. It currently has a total number of 4 (2024) employees. There was a net sales revenue increase of 175.31% reported in Labomedica Ecuador Labomec S.A.S.’s latest financial highlights for 2024. There was a total growth of 1045.62% in Labomedica Ecuador Labomec S.A.S.’s total assets over the same period. In, 2024, the company’s net profit margin increased by 0.07%.

Headquarters
Calle Piedrahita, 225
Guayaquil; Guayas;

Contact Details: Purchase the Labomedica Ecuador Labomec S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Labomedica Ecuador Labomec S.A.S. report to view the information.
Registered Capital:
Purchase the Labomedica Ecuador Labomec S.A.S. report to view the information.
Financial Auditors:
Purchase the Labomedica Ecuador Labomec S.A.S. report to view the information.
Incorporation Date:
April 27, 2023
Key Executives
Purchase this report to view the information.
General Manager
Company Performance
Financial values in the chart are available after Labomedica Ecuador Labomec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
175.31%
Total operating revenue
175.31%
Operating profit (EBIT)
509.52%
EBITDA
509.52%
Net Profit (Loss) for the Period
509.57%
Total assets
1045.62%
Total equity
17.93%
Operating Profit Margin (ROS)
0.08%
Net Profit Margin
0.07%
Return on Equity (ROE)
12.26%
Quick Ratio
-120.39%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?